Valuation: Apyx Medical Corporation

Market Cap 108M 98.16M 90.75M 81.9M 154M 10.06B 160M 1.1B 433M 5.43B 404M 395M 17.14B P/E 2026 *
-12.7x
P/E 2027 * -13.4x
Enterprise Value 108M 98.16M 90.75M 81.9M 154M 10.06B 160M 1.1B 433M 5.43B 404M 395M 17.14B EV / Sales 2026 *
1.81x
EV / Sales 2027 * 1.64x
Free-Float
84.43%
Yield 2026 *
-
Yield 2027 * -
1 day-2.54%
1 week-17.00%
Current month-4.23%
1 month+2.89%
3 months-19.94%
6 months-35.66%
Current year-28.86%
1 week 2.38
Extreme 2.38
2.93
1 month 2.25
Extreme 2.25
3.3
Current year 2.25
Extreme 2.25
5.08
1 year 2.25
Extreme 2.25
5.08
3 years 0.76
Extreme 0.7554
5.08
5 years 0.76
Extreme 0.7554
17.5
10 years 0.76
Extreme 0.7554
17.5
Manager TitleAgeSince
Chief Executive Officer 60 2017-12-14
Director of Finance/CFO 57 2023-12-03
Chief Tech/Sci/R&D Officer - 2019-07-31
Director TitleAgeSince
Director/Board Member 79 2011-03-14
Director/Board Member 60 2017-12-14
Director/Board Member 78 2019-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Exercice

Director

29,024 0.0693%
6/11/26 Free

Chief Operating Officer

88,044 0.2103%
3/15/26 Exercice

Executive/Senior Manager

74,000 0.1804%
Change 5-day change 1-year change 3-year change Capi.($)
-2.54%-17.00%-34.65%+8.26% 108M
-0.22%-4.40%-19.63%+3.24% 181B
-1.56%-0.88%-0.08%+34.01% 125B
+0.19%-0.20%-11.51%+9.98% 121B
+1.12%-3.62%-42.71%+0.79% 90.52B
-0.64%-0.45%-3.69%+77.76% 66.9B
+0.31%+0.73%+12.35%-7.53% 58.68B
+1.19%-0.59%+4.22%+47.69% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+0.71%+1.50%-0.26% 35.4B
Average -0.09%-1.51%-9.60%+21.26% 78B
Weighted average by Cap. -0.07%-1.52%-10.44%+19.62%

Financials

2026 *2027 *
Net sales 59.59M 54.35M 50.25M 45.35M 85.41M 5.57B 88.77M 607M 240M 3.01B 224M 219M 9.49B 65.8M 60.01M 55.49M 50.07M 94.31M 6.15B 98.02M 670M 265M 3.32B 247M 242M 10.48B
Net income -8.73M -7.96M -7.36M -6.64M -12.51M -816M -13M -88.88M -35.13M -440M -32.74M -32.06M -1.39B -8.58M -7.82M -7.23M -6.53M -12.29M -802M -12.78M -87.36M -34.53M -433M -32.18M -31.51M -1.37B
Net Debt - -
Projected Income Statement - Annual - Apyx Medical Corporation
Logo Apyx Medical Corporation
Apyx Medical, Inc., formerly Apyx Medical Corporation, is a surgical aesthetics company. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.
Employees
205
Date Price Change Volume
26-11-18 US$2.490 -2.54% 188,655
26-11-17 US$2.555 -3.58% 46,115
26-11-16 US$2.650 -5.69% 71,230
26-11-13 US$2.810 -2.77% 43,009
26-11-12 US$2.890 -3.67% 128,115
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Apyx Medical Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.555USD
Average target price
6.500USD
Spread / Average Target
+154.40%
  1. Stock Market
  2. Stocks
  3. APYX Stock